0001181431-12-008787.txt : 20120214 0001181431-12-008787.hdr.sgml : 20120214 20120214172525 ACCESSION NUMBER: 0001181431-12-008787 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120210 FILED AS OF DATE: 20120214 DATE AS OF CHANGE: 20120214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Caballa Susan CENTRAL INDEX KEY: 0001489530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34703 FILM NUMBER: 12612883 MAIL ADDRESS: STREET 1: 6120 WINDWARD PARKWAY STREET 2: SUITE 290 CITY: ALPHARETTA STATE: GA ZIP: 30005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALIMERA SCIENCES INC CENTRAL INDEX KEY: 0001267602 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 6120 WINDWARD PARKWAY STREET 2: STE 290 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 6789905740 MAIL ADDRESS: STREET 1: 6120 WINDWARD PARKWAY STREET 2: STE 290 CITY: ALPHARETTA STATE: GA ZIP: 30005 4 1 rrd334155.xml FORM 4 X0304 4 2012-02-10 0 0001267602 ALIMERA SCIENCES INC ALIM 0001489530 Caballa Susan 6120 WINDWARD PARKWAY, SUITE 290 ALPHARETTA GA 30005 0 1 0 0 SVP,Regulatory&Medical Affairs Employee Stock Option (Right to Buy) 1.65 2012-02-10 4 A 0 60000 0 A 2022-02-09 Common Stock 60000 60000 D Employee Stock Option (Right to Buy) 1.65 2012-02-10 4 A 0 25000 0 A Common Stock 25000 25000 D This option shall vest in forty-eight equal monthly installments beginning on March 10, 2012. This option shall vest in full upon receipt by the Issuer, on or prior to August 9, 2013, of approval from the U.S. Food and Drug Administration of the Issuer's New Drug Application for ILUVIEN (the "Vesting Event"). This option shall expire on February 9, 2022, if the Vesting Event occurs. If the Vesting Event does not occur, then the option will expire on August 10, 2013. /s/ Susan H. Caballa 2012-02-13